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AbstrACt
Objectives To estimate the incidence and epidemiology 
of catheter-related bloodstream infections (CRBSIs) on a 
national scale by using prospective epidemiological data 
from the Swiss Antibiotic Resistance Surveillance System 
(ANRESIS).
Design Observational study.
setting National surveillance from 2008 to 2015 of acute 
hospitals in Switzerland.
Participants We included acute Swiss hospitals that 
sent blood cultures and catheter tip culture results on a 
regular basis during the entire study period to the ANRESIS 
database.
Outcome measure A catheter-related bloodstream 
infection (termed ‘modified CRBSI’, mCRBSI) was defined 
as isolating the same microorganism with identical 
antibiogram from ≥1 blood cultures (performed ±7 days 
around the catheter removal) as the one recovered 
from the catheter tip. Incidence rates of mCRBSI were 
calculated per 1000 admissions.
results From 2008 to 2015, the mCRBSI incidence 
rate decreased from 0.83 to 0.58 episodes/1000 
admissions (−6% per year, p<0.001). Coagulase-negative 
staphylococci, Staphylococcus aureus and fungi all 
exhibited decreasing trends, while rates of enterococci and 
Gram-negative bacteria remained stable.
Conclusions The overall incidence of mCRBSI in 
Switzerland is decreasing; however, the incidence of 
mCRBSI due to Enterococci and Gram-negative micro-
organisms did not change over time. These pathogens may 
grow in importance in catheter-related infections, which 
would have clinical implications for the choice of empirical 
treatment.
IntrODuCtIOn 
Catheter-related bloodstream infection 
(CRBSI) or central line-associated blood-
stream infections (CLABSIs) are associ-
ated with increased morbidity, mortality 
and healthcare costs.1 The epidemiology of 
CLABSI has occasionally been evaluated on 
a national scale; however, studies focused 
for the most part on the intensive care unit 
(ICU) setting.2 3 In contrast, very few studies 
investigated CLABSI outside the ICU.4–7 Of 
note, the term CLABSI is used for surveil-
lance purposes (where the definition neither 
requires quantitative criteria nor a microbi-
ological diagnosis of the removed catheter 
tip), whereas the source of infection in CRBSI 
is based on a positive culture of the catheter 
tip. CLABSI surveillance can therefore easily 
lead to an overestimation of the incidence of 
CRBSI.8 More specific definitions based on 
single-institution surveillance studies have 
previously been proposed, including the use 
of admissions9 10 or bed-days11 as denomi-
nator. Such a definition permits the identifi-
cation of the catheter as source of infection, 
considering both catheter tip culture results 
and blood cultures (ie, a ‘modified’ CRBSI). 
Moreover, the incidence of CRBSI has 
rarely been investigated on a national scale 
in European countries, given the difficulty 
in obtaining clinical information. Here, 
we wanted to perform a first estimation of 
strengths and limitations of this study
 ► Provides an estimation of catheter-related blood-
stream infection (CRBSI) on a national scale, an as-
pect rarely investigated in European countries.
 ► The observed trends should not have been affected 
by selection bias given the use of the same CRBSI 
definition throughout the study period.
 ► While surveillance studies on central line-associat-
ed bloodstream infection or CRBSI mostly focused 
on overall incidence rates, we also determined the 
pathogen distribution.
 ► No clinical data were available (patient and catheter 
data).
 ► Only those CRBSI episodes for which the catheter 
was removed and submitted to the laboratory were 
included.
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changes in the epidemiology of CRBSI in Switzerland 
according to the ‘modified’ CRBSI definition, using a 
national microbiological surveillance database.
MethODs
We conducted a nationwide, observational study on 
CRBSI using Swiss Antibiotic Resistance Surveillance 
System (ANRESIS) data from 2008 to 2015. The ANRESIS 
programme summarises all positive blood and catheter 
tip cultures from 20 Swiss laboratories, each of them 
collecting data from several hospitals distributed across 
the country. Accordingly, we analysed data of patients 
from 36 Swiss hospitals, including only those centres that 
sent catheter tip information on a regular basis during the 
entire study period. All five Swiss university hospitals and 
the main regional hospitals were included, representing 
the majority of hospitalised patients in the country during 
the study period.
A catheter tip was included in the analysis if at least one 
microorganism could be cultivated, irrespective of the 
cut-off of the roll plate method.12 In case of a polymicro-
bial CBRSI, each microorganism isolated was considered 
as a single event. Information about the microbiolog-
ical method (quantitative sonication vs semiquantitative 
roll plate culture) was not routinely made available by the 
participating laboratories. However, in a previous analysis 
using a similar dataset, 83% of the participating laborato-
ries used the semiquantitive roll plate culture method.13 
Additional culture tip reports of another catheter tip with 
the same microorganism in the same patient within 7 days 
were excluded.
A catheter-related bloodstream infection, here termed 
‘modified CRBSI’ (mCRBSI), was defined as isolating 
the same micro-organism with identical antibiogram 
from ≥1 blood cultures (performed ±7 days around 
the catheter removal) as the one recovered from the 
catheter tip. CRBSI episodes diagnosed by differential 
time-to-positivity or quantitative blood cultures could 
not be included because this information was not avail-
able from the participating laboratories. Incidence rates 
of mCRBSI were calculated per 1000 admissions using 
national data on hospital statistics.14 With this definition, 
a satisfactory correlation between mCRBSI and CLABSI 
was previously documented.9 From 2008 to 2015, an 
increase of hospital admissions was observed14; therefore, 
a supplementary analysis using hospital-days as denomi-
nator was performed.14 Moreover, a supplementary anal-
ysis using a stricter definition of mCRBSI (isolation of 
the same microorganism in blood cultures performed −7 
days to +2 days around the catheter removal and in the 
catheter tip cultures) was performed. We then performed 
trend analyses for the following micro-organism groups: 
Staphylococcus aureus, coagulase-negative staphylococci 
(CoNS), enterococci, Enterobacteriaceae, Gram-negative 
non-fermenters, anaerobes and fungi. For Enterobacte-
riaceae, Gram-negative non-fermenters and enterococci, 
we performed a trend analysis of resistance to ceftriaxone, 
cefepime and vancomycin, respectively. A subanalysis of 
the following categories was conducted: age (<65 vs ≥65 
years), gender (male vs female), department (ICU vs 
non-ICU) and type of hospital (community vs university 
hospital).
Group comparisons were performed using Student’s 
t-test for normally distributed continuous variables, 
with the Mann-Whitney-Wilcoxon test for non-normally 
distributed continuous variables or with Pearson’s χ2 test 
for dichotomous variables. Models for the overall rate 
increase per year, adjusted for each of gender, age, type of 
hospital, department and pathogen (seven groups) were 
fitted in turn using a Poisson regression model including 
an offset for the estimated admissions/bed-days in the 
respective year.
Since the analysis was performed from anonymised 
non-genetic surveillance data, neither approval from 
an ethics committee nor patient consent was required 
according to the Swiss law for research on human beings 
(Art. 33 al. 2 LRH).
Patient and public involvement
No patients were involved in the design, recruitment or 
conduct of this study.
results
A total of 2741 mCRBSI episodes were reported between 
2008 and 2015, with a mean incidence rate of 342 episodes 
per year. Twenty-six per cent of the episodes (n=714) 
occurred in ICU departments and 43% (n=1177) were 
detected in university hospitals.
The mCRBSI incidence rate decreased from 0.83 to 
0.58 episodes/1000 admissions during the study period 
(−6% per year, p<0.001; figure 1). The total number of 
admissions increased from 469 816 in 2008 to 533 017 in 
2015. A supplementary analysis using patient-days (which 
remained constant during the study period) as denom-
inator showed similar trends (cf. online supplementary 
Figure 1 Incidence of modified catheter-related 
bloodstream infection (mCRBSI) per 1000 hospital 
admissions: overall trends and subgroups. All trends were 
significant. ICU, intensive care unit. 
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figures A,B). Moreover, comparable trends were observed 
when limiting the analysis to bloodstream infection 
episodes −7 days to +2 days around the catheter removal 
(cf. online supplementary figure C). The most notable 
trends were observed in individuals aged ≥65 years (−3% 
per year, p=0.04), in university hospitals (−4% per year, 
p=0.009) and in ICU departments (−4% per year, p=0.04).
CoNS (−7% per year, p<0.001), S. aureus (−10% per year, 
p<0.001) and fungi (−20% per year, p<0.001) all exhibited 
decreasing trends (figure 2). On the other hand, entero-
cocci (+3%, p=0.39), Enterobacteriaceae (−2% per year, 
p=0.25) and Gram-negative non-fermenters (−5%, p=0.1) 
remained stable over the study period without statistically 
significant trends. No pathogen group showed an upward 
rate trend over the study period.
Among Enterobacteriaceae (n=681), a slight non-sig-
nificant increase in ceftriaxone resistance was observed 
during the study period. A significant upward trend in 
vancomycin resistance was noted in enterococci (n=116). 
No significant trend was found in cefepime resistance 
in Gram-negative non-fermenters (n=182) (cf. online 
supplementary figures D1–D3).
DIsCussIOn
Catheter-related infections can either be identified 
for surveillance purpose (CLABSI) or in clinical terms 
(CRBSI). Here, we present data from a large surveillance 
study in 36 hospitals across Switzerland, corresponding to 
approximately 38% of all national hospital admissions in 
201514. Our study appears to mirror a trend of decreasing 
incidence of CLABSI seen elsewhere, using the more 
precise and clinically oriented definition of mCRBSI. Our 
report could be of particular interest to other countries 
where no nationwide surveillance of CLABSI has been 
established yet. Indeed, the main finding of this anal-
ysis is that, overall, mCRBSI decreased both in ICU and 
non-ICU patients. A comparison with other surveillance 
studies is difficult, since few studies relied on this (or a 
similar) case definition.10 11 15 Our definition was in fact 
closely linked to one used by Rodriguez-Créixems et al.9 
Possible reasons for the observed decrease of the mCRBSI 
rate may include: (1) implementation of national initia-
tives aimed at improving standards in hospital infec-
tion prevention,16 (2) a decreasing average duration of 
hospitalisation with early discharge of patients poten-
tially prone to develop CRBSI17; (3) changing policies 
in recommending tip cultures to be taken if a catheter 
is removed; possibly, catheter tip cultures were less and 
less frequently recommended by local clinicians over the 
course of the study period and (4) an increasing number 
of admissions from 2008 to 2015 could have led to an 
apparent decrease in the incidence of mCRBSI. However, 
a supplementary analysis using patient-days as denomi-
nator revealed similar trends as the main analysis.
Interestingly, the incidence of CoNS, S. aureus 
and fungi decreased significantly over time, while 
Gram-negative microorganisms and Enterococci 
remained stable over the study period. These stable 
trends are of particular concern, since both Entero-
cocci and Gram-negative infections may be associated 
with high resistance and mortality rates.18 19 A rise 
in vancomycin resistance in Enterococci was noted, 
but given that only four samples showed vancomycin 
resistance this finding remains difficult to interpret. 
No significant increase in resistance Gram-nega-
tive bacteria could be detected. While surveillance 
studies on CLABSI or CRBSI mostly focused on 
overall incidence rates, comparatively little atten-
tion has been drawn to the pathogen distribution of 
catheter-related infections. Recently published data 
showed that enterococcal catheter infections either 
predominated in terms of pathogen distribution6 20 
or showed increasing trends in two reports.2 21 Similar 
trends or patterns were observed for Gram-negative 
CRBSI.11 22 23 It is conceivable that the improved stan-
dards in hospital infection prevention have had less 
impact on these particular microorganism groups.22 
An increase in multidrug-resistant strains or the rise 
in the medical complexity of hospital patients might 
be further reasons for these trends.23 Most epide-
miological studies so far have neglected to focus on 
Gram-negative bacteria and Enterococci as causes of 
catheter infections. We are convinced that further 
research should focus on these two subsets of CRBSI.
Our study has several limitations. First, our defini-
tion of mCRBSI is highly specific and some cases of 
catheter-related infections might have been missed. 
In particular, only those CRBSI in which the catheter 
was removed and submitted to the laboratory were 
included, which may have led to an underestimation 
of the total burden of catheter-related infections. 
However, the same criteria for identifying CRBSI were 
used throughout the study period and, therefore, the 
observed trends should have not be affected. The 
Figure 2 Incidence of mCRBSI caused by CoNS, 
Staphylococcus aureus, enterococci, Enterobacteriaceae, 
Gram-negative non-fermenters and fungi. CoNS, coagulase-
negative staphylococci; ICU, intensive care unit; mCRBSI, 
modified catheter-related bloodstream infection.
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inclusion of cases with only one positive blood culture 
for commensals could have led to an overestimation of 
the CRBSI rate (eg, in case of colonisation or contam-
ination). However, by requiring a positive catheter 
tip we think that this effect has been mitigated. By 
including episodes up to 7 days after the catheter 
removal, non-catheter-related infections may have 
been included. However, a satisfactory correlation 
between mCRBSI and CLABSI has previously been 
documented in ICU patients.9 Second, neither infor-
mation on the catheter type nor pertinent clinical data 
was available, which may have led to the inclusion of 
peripheral venous/arterial catheters or catheter tips 
sent without clinical indication. Finally, using admis-
sion as denominator, possible changes in device days 
were not considered. However, we believe that this 
drawback is outweighed by the advantage of obtaining 
reliable mCRBSI trends where clinical surveillance was 
not feasible. We were unable to correlate the CLABSI 
rates with our results of mCRBSI, since there is no 
national CLABSI surveillance in Switzerland yet; to 
assess the gap between rates of CLABSI and mCRBSI 
on a national scale would be an interesting next step.
Our data suggest that the overall incidence of 
mCRBSI in Switzerland is decreasing; however, 
mCRBSI due to Enterococci and Gram-negative micro-
organisms did not change over time. These pathogens 
may grow in importance in catheter-related infections, 
which would have clinical implications for the choice 
of empirical treatment.
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